840 related articles for article (PubMed ID: 27271600)
21. Matrix-degrading metalloproteinases in photoaging.
Quan T; Qin Z; Xia W; Shao Y; Voorhees JJ; Fisher GJ
J Investig Dermatol Symp Proc; 2009 Aug; 14(1):20-4. PubMed ID: 19675548
[TBL] [Abstract][Full Text] [Related]
22. [Matrix metalloproteinases and colorectal cancer].
Roeb E; Matern S
Med Klin (Munich); 2003 Dec; 98(12):763-70. PubMed ID: 14685678
[TBL] [Abstract][Full Text] [Related]
23. Current Perspectives on the Role of Matrix Metalloproteinases in the Pathogenesis of Basal Cell Carcinoma.
Tampa M; Georgescu SR; Mitran MI; Mitran CI; Matei C; Caruntu A; Scheau C; Nicolae I; Matei A; Caruntu C; Constantin C; Neagu M
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34204372
[TBL] [Abstract][Full Text] [Related]
24. Distinct progression-associated expression of tumor and stromal MMPs in HaCaT skin SCCs correlates with onset of invasion.
Vosseler S; Lederle W; Airola K; Obermueller E; Fusenig NE; Mueller MM
Int J Cancer; 2009 Nov; 125(10):2296-306. PubMed ID: 19610062
[TBL] [Abstract][Full Text] [Related]
25. Ultraviolet-B irradiation and matrix metalloproteinases: from induction via signaling to initial events.
Brenneisen P; Sies H; Scharffetter-Kochanek K
Ann N Y Acad Sci; 2002 Nov; 973():31-43. PubMed ID: 12485830
[TBL] [Abstract][Full Text] [Related]
26. Biology of metalloproteinases.
Amălinei C; Căruntu ID; Bălan RA
Rom J Morphol Embryol; 2007; 48(4):323-34. PubMed ID: 18060181
[TBL] [Abstract][Full Text] [Related]
27. 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro.
Pickett KL; Harber GJ; DeCarlo AA; Louis P; Shaneyfelt S; Windsor LJ; Bodden MK
J Dent Res; 1999 Jul; 78(7):1354-61. PubMed ID: 10403463
[TBL] [Abstract][Full Text] [Related]
28. [Matrix metalloproteinases and their tissue inhibitors in malignancies of the female genital tract].
Piura B; Rabinovich A; Huleihel M
Harefuah; 2003 Nov; 142(11):786-91, 804. PubMed ID: 14631913
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinases in tumor-host cell communication.
Lynch CC; Matrisian LM
Differentiation; 2002 Dec; 70(9-10):561-73. PubMed ID: 12492497
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinases in tumor invasion.
Johansson N; Ahonen M; Kähäri VM
Cell Mol Life Sci; 2000 Jan; 57(1):5-15. PubMed ID: 10949577
[TBL] [Abstract][Full Text] [Related]
31. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Matsunaga Y; Koda M; Murawaki Y
Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the extracellular matrix remodeling by lutein in dermal fibroblasts, melanoma cells, and ultraviolet radiation exposed fibroblasts.
Philips N; Keller T; Hendrix C; Hamilton S; Arena R; Tuason M; Gonzalez S
Arch Dermatol Res; 2007 Oct; 299(8):373-9. PubMed ID: 17710425
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinase enzymes and their naturally derived inhibitors: novel targets in photocarcinoma therapy.
Gupta A; Kaur CD; Jangdey M; Saraf S
Ageing Res Rev; 2014 Jan; 13():65-74. PubMed ID: 24355347
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.
Raffetto JD; Khalil RA
Biochem Pharmacol; 2008 Jan; 75(2):346-59. PubMed ID: 17678629
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy.
Thrailkill KM; Clay Bunn R; Fowlkes JL
Endocrine; 2009 Feb; 35(1):1-10. PubMed ID: 18972226
[TBL] [Abstract][Full Text] [Related]
36. Role of matrix metalloproteinases in melanoma cell invasion.
Hofmann UB; Houben R; Bröcker EB; Becker JC
Biochimie; 2005; 87(3-4):307-14. PubMed ID: 15781317
[TBL] [Abstract][Full Text] [Related]
37. The role of the IGF-I receptor in the regulation of matrix metalloproteinases, tumor invasion and metastasis.
Zhang D; Samani AA; Brodt P
Horm Metab Res; 2003; 35(11-12):802-8. PubMed ID: 14710361
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinases and their tissue inhibitors in the developing neonatal mouse uterus.
Hu J; Zhang X; Nothnick WB; Spencer TE
Biol Reprod; 2004 Nov; 71(5):1598-604. PubMed ID: 15240428
[TBL] [Abstract][Full Text] [Related]
39. Pleiotropic Roles of Metalloproteinases in Hematological Malignancies: an Update.
Chaudhary AK; Chaudhary S; Ghosh K; Nadkarni A
Asian Pac J Cancer Prev; 2016; 17(7):3043-51. PubMed ID: 27509927
[TBL] [Abstract][Full Text] [Related]
40. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]